Ninety years ago, Carlos Chagas, a Brazilian physician, made a remarkable discovery (Chagas 1909a (Chagas ,b,c, 1910 . In the period of a few months, Chagas was introduced to a blood sucking insect, identified trypanosomes in its midgut, carried out experiments on infection and invented a disease: the American trypanosomiasis, or Chagas disease. Thus stated, the sequence seems hardly real and the whole episode, unexpected. However, given the international scientific context of turn of the century tropical medicine (Harden 1985 , Worboys 1976 , it was not. Chagas' sequence from vector to disease is the most paradigmatic employment ever done of the insect-vector theory, tropical medicine's central guideline in those days (Coutinho & Dias 1999) . It was the tropical adventure dream of every parasite hunter, available only to the best and the luckiest. It is therefore easy to understand the enthusiasm with which Chagas' discovery was received by the international community (Chagas Filho 1974 , Coutinho & Dias 1999 .
Recognition means different things for different disciplines in different times. It includes invitations for conferences, citations, collaborative research and awards. Chagas had his share of all that (Chagas Filho 1993) . However, in the golden years of tropical medicine, when it was one of the most prestigious sciences, it could certainly mean the Nobel prize. Other parasite hunters, such as R Ross in 1902 and A Laveran in 1907, were Nobel laureates (the Nobel Foundation 1999). As the author of the most impeccable of those early discoveries, Chagas was obviously on the Nobel track. And, in fact, he was nominated for the prize, not only once, but twice officially and twice unofficially (Coutinho 1999) . We are publishing here for the first time the fac similes of the two official Nobel nominations -one for the 1913 and the other for the 1921 Prize. None of them resulted in an award for Chagas. Now, THIS is unexpected and extraordinary.
To understand this puzzle, we must refer to the institutional setting and to the interplay of relevant characters in the reception of Chagas' discovery.
THE CIRCLE OF PARASITE HUNTERS
In this year of 1999, we are celebrating more than the 90 years of Chagas' discovery. We are celebrating the 100th birthday of tropical medicine. In 1899 two institutions and official support were granted to the circle of parasite hunters. In that year, P Manson, the founder of tropical medicine, defined tropical diseases as those caused by parasites that required an intermediary host in which part of the parasite's life cycle was to be completed. The "insect-vector" theory predicted that the vec-tor would be a blood sucking arthropod, most probably an insect (Harden 1985) . This definition provided both the conceptual core for the early practitioners and a strong argument for tropical medicine's (institutional and educational) independence from bacteriology and "traditional" medicine (Worboys 1993) . The new specialty dealt with tropical, as opposed to cosmopolitan diseases; they were caused by protozoa or more complex organisms, instead of bacteria or viruses; finally, they were transmitted by vectors, in contrast to the mechanical transmission of bacterial diseases. Such costly disciplinary independence was granted to a group of marginal army physicians partly because of the enormous importance that the sanitation of tropical possessions was assuming. In the last decades of the XIX century, the British Empire alone had grown into a vast tropical domain, chiefly in Africa. The health of white soldiers and settlers was permanently threatened by tropical diseases. Tropical medicine was, for these people, colonial and military business (Curtin 1989 , Farley 1991 , Worboys 1993 .
With a list of impressive discoveries, institutions and resources for research, and the political support from colonial powers' governments, tropical medicine flourished as one of the most prestigious sciences of the early XX century (Worboys 1976 (Worboys , 1993 . The discoveries included the elucidation of filariasis transmission by mosquitoes by P Manson in 1879; the identification of the malaria Plasmodium parasites, by A Laveran in 1880; the identification of the malaria insect vector and life cycle by R Ross and GB Grassi in 1897; the discovery of the causative agent of Kala azar, Leishmania donovani, by WB Leishman and C Donovan in 1900; the discovery of African trypanosomiasis by Bruce, between 1896 and 1902 and the identification of the life cycle of Schistosoma worms, that caused bilharzia, by R Leiper in 1915 (Farley 1991 , Worboys 1983 , Desowitz 1993 ).
AN UNUSUAL DISCOVERY
The close connections and present historical confusion between tropical medicine, colonial medicine and military medicine probably add to the oddity of Chagas' discovery: he was not European, Brazil was not a colony and Chagas' job had nothing to do with the military, much less with conquests and empires. Chagas' job concerned national development. Chagas worked for the Instituto Soroterápico de Manguinhos and, in 1907, he was sent to a small village in Minas Gerais to control a malaria epidemic. The outbreak had obstructed the construction of the Central do Brasil railroad (Chagas 1907) .
In Lassance, Chagas was introduced, in 1908, to a blood sucking reduviid insect that preyed on the people at night. The general health condition was poor and strange symptoms called Chagas' attention. He dissected the insects and found critidia-like parasites in their gut. Assuming the protozoan could be an intermediary form of a vertebrate hemo-flagellate, Chagas sent some insects to Manguinhos for experimental infection. The parasites proved to be infective and to cause serious symptoms or kill the laboratory animals. In March 1909, Chagas found his first acute human case in Lassance (Chagas 1909c (Chagas , 1922 .
Chagas had just performed the perfect algorithm from vector to disease within a few months and alone. Compared to all the other tropical diseases, in which the discovery saga involved many years and many people, Chagas' discovery is again unusual. For example: the etiologic agent of bilharzia, the Schistosoma worms, were discovered between 1851 and 1852 by Theodor Bilharz. He identified the worms and its eggs. The life cycle and species were only correctly identified in 1915. The parasite that causes Kala azar was discovered in 1900 by Leishman and Donovan. Years after, it was identified as a protozoan of the genus Leishmania. The vector, Phlebotomus argentipes, was identified twenty six years later. Finally, the transmission mechanism became known only in 1940. The causative agent for malaria, a disease known from ancient times, was first observed in 1880 by Laveran. However, the transmission by the mosquito was only established in 1897 by Ross.
Word spread throughout the world about Chagas' remarkable discovery. He was immediately recognized. In 1910, Chagas was named full member of the Academia Brasileira de Medicina (National Academy of Medicine). Between 1911 and 1912 Chagas was invited to speak and to receive honors in Minas Gerais and São Paulo. In 1912, Chagas received the Schaudinn Prize, an international competition sponsored by the Institut für Schiffs-und Tropenkrankheiten of Hamburg. The prize was endowed to the most important contribution in protozoology every four years. Chagas won the award. The contenders were P Ehrlich, E Roux, E Metchnikoff, A Laveran, C Nicolle e WB Leishman (Chagas Filho 1993 , Fonseca Filho 1974 . Except for Leishman, they were all or became afterwards Nobel laureates: Laveran, in 1907; Ehrlich and Metchnikoff, in 1908; and Nicolle, in 1928 (the Nobel Foundation 1999) .
THE NOMINATIONS
The Nobel Commission accepts nominations if they are made by specially appointed scientists. In 1911, the Commission assigned the task to Pirajá da Silva (Ringertz 1998) .
Pirajá da Silva understood well the meaning of recognition. He had recently had some experience with credit attribution. In 1908, Pirajá da Silva wrote to Patrick Manson about the identification of Schistosoma eggs with lateral spines. The question was prompted by his repeated encounters with these eggs in the feces of his patients in Bahia, Brazil. At that time, an important controversy was going on about the number of species of Schistosoma worms, as well as the types of diseases they caused (Farley 1991 (Silva 1908 (Silva /09, 1909 . In 1912, Pirajá da Silva described, for the first time, a Schistosoma cercaria (Silva 1912) , providing evidence for the complicated cycle of this flatworm. In spite of all the evidence, a good part of the international community, led by Leiper, ignored him and denied him credit for his work. He was never fully recognized as the true discoverer of Schistosoma mansoni and isn't even mentioned regarding the elucidation of the parasite's life cycle [In 1954 , Pirajá da Silva was awarded the Bernhard Nocht medal, conferred by the Institut für Schiffsund Tropenkrankheiten. In the letter from Ernst Nauck, then director of the German institution, Pirajá da Silva is referred to as the scholar who settled a controversy over a previous discovery. In 1953, Philip Manson-Bahr published a review in which he acknowledged that Pirajá da Silva was the first researcher to describe the parasite that is now known as Schistosoma mansoni (MansonBahr 1953) ].
Piraja da Silva's emphasis on Chagas' parasitological contribution in his nomination letter must be understood in the light of the latter's bitter experience.
Chagas did not receive the 1913 Nobel prize, which was awarded to CR Richet for his work on anaphylaxis (The Nobel Foundation 1999) .
In 1920, the Nobel Commission assigned the task of nominating the candidate to H Gouvêa, a physician from Rio de Janeiro. This time, the longer letter insists on the medical significance of Chagas' findings. One of the reasons for this is that tropical medicine had lost much of its parasitological bias. After World War I, concerns over health in the tropics declined in the major European countries and the dominant approach in tropical medicine shifted from parasites and vectors to nutrition and environment (Worboys 1983) .
Again, Chagas did not receive the prize. Having failed to confirm Chagas, the Commission did not award the prize to anyone in 1921.
If Chagas' contribution was deemed important by everyone that counted, why were the nominations turned down? Some other source of opposition must have been at work.
OPPOSITION AT HOME
And in fact, opposition there was from the beginning. The unfolding of Chagas' discovery included not only honors and awards, but prominent positions and power. For each step Chagas took on the success ladder, the anti-Chagas group grew in number and resolve. As soon as 1910, Chagas was named head of Service in Manguinhos. The procedure that resulted in his nomination was strictly based on merit, according to a clear set of rules. Some were displeased -HB de Aragão, for one -both with the procedure and with Chagas' nomination. Hostility began to brew there (Chagas Filho 1993 , Benchimol & Teixeira 1993 .
The surreptitious actions of the early antiChagas group came forth little by little. In 1916, at the Pan-American Medical Congress in Argentina, Chagas had a hard argument with R Kraus, from Argentina's Bacteriological Institute. Kraus claimed that he had found infected reduviid insects but no human victim of Chagas disease in Argentina (Fonseca Filho 1974 , Chagas Filho 1974 . The implications were serious and either meant that the parasite could be of little virulence, or the disease had only a local importance. In that occasion, Chagas was invited to visit Kraus' laboratory. There he found slides with Manguinhos stamps. He did not remember having ever received requests from Kraus (Chagas Filho 1993 (Chagas Filho 1993) .
Another important source of opposition was the prominent and controversial role Chagas played in Brazilian public health. The Department of Public Health was created in 1920 and Chagas was named director. Afrânio Peixoto, a powerful man in the Brazilian medical establishment, was upset (Chagas Filho 1993 "You could have found some mosquitoes, you could have invented a rare and unknown disease, about which much was said, but whose victims almost no one knew, hidden in a countryside dwelling of your province, a disease that you could magnanimously distribute among your fellow countrymen, accused of cretins" (Afrânio Peixoto, in Fonseca Filho 1974, p. 65) .
Chagas demanded that a commission be formed to judge whether the disease was a new morbid entity, with well defined etio-pathogeny, characteristic symptoms and defined clinical syndromes and also judge his ethical procedure, the credits of his findings and its scientific and social relevance. The whole process took more than one year. In December 6, 1924, the commission decided in Chagas' favor (Fonseca Filho 1974 , Chagas Filho 1993 . However, it took another decade to re-establish the full recognition of Chagas' discovery: it was only after Chagas' death, in 1934 , that research was again pursued and preventive measures were developed.
Whatever inquiries and oral debates there were following Chagas' nominations for the Nobel Prize faced an active anti-Chagas group at work in Manguinhos and at the Academia Nacional de Medicina. Stealthy and cautious in 1913, loud and aggressive in 1921. At this point, a second reason for Gouvêa's stress on the clinical aspects of Chagas' discovery is visible. In 1920, the disease itself was at stake and there were those that claimed that it was not a disease at all, or it was something of minor importance, restricted to a few areas.
Sierra Iglesias (1990) speculates that it was this local opposition that actually prevented Chagas from being awarded the Nobel prize in 1921, the only nomination the author had knowledge of. We have found no documental evidence for that to this moment. However, the idea seems highly plausible.
Chagas' failure to be awarded the Nobel prize remains a mystery. However, this story sheds some light on previously neglected aspects of the adversities faced by scientists from scientifically nontraditional countries in getting recognition for their work. Even when they qualify as practitioners of the same scientific specialty, sharing concepts, issues and methods with their colleagues from scientifically traditional countries, they are somewhat outsiders. There are different sets of interests, institutions and political arrangements involved. But worst of all, they might be outsiders in their own countries, struggling to establish research in an environment that does not understand its role, and to function according to meritocratic rules that are utterly ignored. They are weak players abroad and they are weak players at home, where the elsewhere undisputed place of the scientist in society is still being carved.
